Metabolic syndrome and risk of cardiovascular disease: A meta-analysis

被引:893
作者
Galassi, Andrea
Reynolds, Kristi
He, Jiang
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA
[2] Tulane Univ, Dept Med, Sch Med, New Orleans, LA 70112 USA
关键词
metabolic syndrome; meta-analysis; cardiovascular disease;
D O I
10.1016/j.amjmed.2006.02.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: The use of different definitions of the metabolic syndrome has led to inconsistent results on the association between the metabolic syndrome and risk of cardiovascular disease. We examined the association between the metabolic syndrome and risk of cardiovascular disease. METHODS: A MEDLINE search (1966- April 2005) was conducted to identify prospective studies that examined the association between the metabolic syndrome and risk of cardiovascular disease. Information on sample size, participant characteristics, metabolic syndrome definition, follow-up duration, and end-point assessment was abstracted. RESULTS: Data from 21 studies met the inclusion criteria and were included. Individuals with the metabolic syndrome, compared to those without, had an increased mortality from all causes (relative risk [RR] 1.35; 95% confidence interval [CI], 1.17- 1.56) and cardiovascular disease (RR 1.74; 95% CI, 1.29- 2.35); as well as an increased incidence of cardiovascular disease (RR 1.53; 95% CI, 1.26- 1.87), coronary heart disease (RR 1.52; 95% CI, 1.37- 1.69) and stroke (RR 1.76; 95% CI, 1.37- 2.25). The relative risk of cardiovascular disease associated with the metabolic syndrome was higher in women compared with men and higher in studies that used the World Health Organization definition compared with studies that used the Adult Treatment Panel III definition. CONCLUSION: This analysis strongly suggests that the metabolic syndrome is an important risk factor for cardiovascular disease incidence and mortality, as well as all-cause mortality. The detection, prevention, and treatment of the underlying risk factors of the metabolic syndrome should become an important approach for the reduction of the cardiovascular disease burden in the general population. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:812 / 819
页数:8
相关论文
共 35 条
  • [1] Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?
    Anderson, JL
    Horne, BD
    Jones, HU
    Reyna, SP
    Carlquist, JF
    Bair, TL
    Pearson, RR
    Lappé, DL
    Muhlestein, JB
    [J]. CARDIOLOGY, 2004, 101 (04) : 185 - 193
  • [2] [Anonymous], 2005, IDF CONS WORLDW DEF
  • [3] Balkau B, 1999, DIABETIC MED, V16, P442
  • [4] Begg C.B., 1994, HDB RES SYNTHESIS, P399
  • [5] The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
    Bonora, E
    Targher, G
    Formentini, G
    Calcaterra, F
    Lombardi, S
    Marini, F
    Zenari, L
    Saggiani, F
    Poli, M
    Perbellini, S
    Raffaelli, A
    Gemma, L
    Santi, L
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETIC MEDICINE, 2004, 21 (01) : 52 - 58
  • [6] Carotid atherosclerosis and coronary heart disease in the metabolic syndrome - Prospective data from the Bruneck Study
    Bonora, E
    Kiechl, S
    Willeit, J
    Oberhollenzer, F
    Egger, G
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2003, 26 (04) : 1251 - 1257
  • [7] Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 3 diabetes
    Bruno, G
    Merletti, F
    Biggeri, A
    Bargero, G
    Ferrero, S
    Runzo, C
    Cerai, SP
    Pagano, G
    Cavallo-Perin, P
    [J]. DIABETES CARE, 2004, 27 (11) : 2689 - 2694
  • [8] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [9] Diercks GFH, 2002, CAN J CARDIOL, V18, P525
  • [10] Einhorn Daniel, 2003, Endocr Pract, V9, P237